These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16556548)

  • 1. Specific lipoplex-mediated antisense against Bcl-2 in breast cancer cells: a comparison between different formulations.
    Meidan VM; Glezer J; Salomon S; Sidi Y; Barenholz Y; Cohen JS; Lilling G
    J Liposome Res; 2006; 16(1):27-43. PubMed ID: 16556548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and pharmacokinetic properties associated with the therapeutics of bcl-2 antisense oligonucleotide G3139 combined with free and liposomal doxorubicin.
    Lopes de Menezes DE; Hudon N; McIntosh N; Mayer LD
    Clin Cancer Res; 2000 Jul; 6(7):2891-902. PubMed ID: 10914739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydration of lipoplexes commonly used in gene delivery: follow-up by laurdan fluorescence changes and quantification by differential scanning calorimetry.
    Hirsch-Lerner D; Barenholz Y
    Biochim Biophys Acta; 1999 Nov; 1461(1):47-57. PubMed ID: 10556487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes.
    Chiu SJ; Liu S; Perrotti D; Marcucci G; Lee RJ
    J Control Release; 2006 May; 112(2):199-207. PubMed ID: 16564596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ; Marcucci G; Lee RJ
    Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid Nanoparticles Loaded with an Antisense Oligonucleotide Gapmer Against Bcl-2 for Treatment of Lung Cancer.
    Cheng X; Liu Q; Li H; Kang C; Liu Y; Guo T; Shang K; Yan C; Cheng G; Lee RJ
    Pharm Res; 2017 Feb; 34(2):310-320. PubMed ID: 27896589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK)(2) and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy.
    Ko YT; Falcao C; Torchilin VP
    Mol Pharm; 2009; 6(3):971-7. PubMed ID: 19317442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide lipoplexes: the influence of oligonucleotide composition on complexation.
    Meidan VM; Glezer J; Amariglio N; Cohen JS; Barenholz Y
    Biochim Biophys Acta; 2001 Dec; 1568(3):177-82. PubMed ID: 11786223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamellarity of cationic liposomes and mode of preparation of lipoplexes affect transfection efficiency.
    Zuidam NJ; Hirsch-Lerner D; Margulies S; Barenholz Y
    Biochim Biophys Acta; 1999 Jul; 1419(2):207-20. PubMed ID: 10407072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural optimization and additional targets identification of antisense oligonucleotide G3139 encapsulated in a neutral cytidinyl-lipid combined with a cationic lipid in vitro and in vivo.
    Ma Y; Zhao W; Li Y; Pan Y; Wang S; Zhu Y; Kong L; Guan Z; Wang J; Zhang L; Yang Z
    Biomaterials; 2019 Mar; 197():182-193. PubMed ID: 30660994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient delivery of antisense oligodeoxyribonucleotide g3139 by human serum albumin-coated liposomes.
    Weecharangsan W; Yu B; Zheng Y; Liu S; Pang JX; Lee LJ; Marcucci G; Lee RJ
    Mol Pharm; 2009; 6(6):1848-55. PubMed ID: 19725564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
    Loomis R; Carbone R; Reiss M; Lacy J
    Clin Cancer Res; 2003 May; 9(5):1931-9. PubMed ID: 12738752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
    Zuidam NJ; Barenholz Y
    Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Bcl-2 modulation with G3139 antisense oligonucleotide on human breast cancer cells are independent of inherent Bcl-2 protein expression.
    Chi KC; Wallis AE; Lee CH; De Menezes DL; Sartor J; Dragowska WH; Mayer LD
    Breast Cancer Res Treat; 2000 Oct; 63(3):199-212. PubMed ID: 11110054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
    Gekeler V; Gimmnich P; Hofmann HP; Grebe C; Römmele M; Leja A; Baudler M; Benimetskaya L; Gonser B; Pieles U; Maier T; Wagner T; Sanders K; Beck JF; Hanauer G; Stein CA
    Oligonucleotides; 2006; 16(1):83-93. PubMed ID: 16584297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
    Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
    Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cells.
    Wasan EK; Waterhouse D; Sivak O; Bally MB; Klasa RJ; Wasan KM
    Int J Pharm; 2002 Jul; 241(1):57-64. PubMed ID: 12086721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment of Bcl-2 antisense oligodeoxynucleotides (G3139), p-glycoprotein inhibitor (PSC833), and sterically stabilized liposomal doxorubicin suppresses growth of drug-resistant growth of drug-resistant breast cancer in severely combined immunodeficient mice.
    Lopes de Menezes DE; Hu Y; Mayer LD
    J Exp Ther Oncol; 2003; 3(2):72-82. PubMed ID: 12822513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin receptor targeted lipopolyplexes for delivery of antisense oligonucleotide g3139 in a murine k562 xenograft model.
    Zhang X; Koh CG; Yu B; Liu S; Piao L; Marcucci G; Lee RJ; Lee LJ
    Pharm Res; 2009 Jun; 26(6):1516-24. PubMed ID: 19291371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of organ vascularization and lipoplex-serum initial contact in intravenous murine lipofection.
    Simberg D; Weisman S; Talmon Y; Faerman A; Shoshani T; Barenholz Y
    J Biol Chem; 2003 Oct; 278(41):39858-65. PubMed ID: 12869564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.